Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
NVIDIA
NVDA
|
+$546M |
| 3 |
Boeing
BA
|
+$405M |
| 4 |
Linde
LIN
|
+$405M |
| 5 |
Exxon Mobil
XOM
|
+$316M |
Top Sells
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.42B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$319M |
| 3 |
Microsoft
MSFT
|
+$292M |
| 4 |
Accenture
ACN
|
+$277M |
| 5 |
Lam Research
LRCX
|
+$271M |
Sector Composition
| 1 | Technology | 26.07% |
| 2 | Healthcare | 13.09% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOCS
1576
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $8.33M | ﹤0.01% |
160,573
-22,901
| -12% | -$1.19M |
|
1577
Denali Therapeutics
DNLI
$2.07B
| $8.31M | ﹤0.01% |
360,636
-15,111
| -4% | -$348K |
|
1578
V2X
VVX
$1.7B
| $8.3M | ﹤0.01% |
209,060
+14,978
| +8% | +$595K |
|
1579
Agios Pharmaceuticals
AGIO
$2.14B
| $8.3M | ﹤0.01% |
361,192
-9,536
| -3% | -$219K |
|
1580
Tencent Music
TME
$38.5B
| $8.29M | ﹤0.01% |
1,001,217
-108,880
| -10% | -$902K |
|
|
ARCH
1581
DELISTED
Arch Resources, Inc.
ARCH
| $8.25M | ﹤0.01% |
62,773
-734
| -1% | -$96.5K |
|
1582
Confluent
CFLT
$6.63B
| $8.24M | ﹤0.01% |
342,359
-10,700
| -3% | -$258K |
|
1583
CONMED
CNMD
$1.64B
| $8.21M | ﹤0.01% |
79,091
-1,568
| -2% | -$163K |
|
|
WSR
1584
Whitestone REIT
WSR
$664M
| $8.2M | ﹤0.01% |
891,235
+139,542
| +19% | +$1.28M |
|
1585
Unifirst Corp
UNF
$3.18B
| $8.18M | ﹤0.01% |
46,398
-4,870
| -9% | -$858K |
|
1586
Clarivate
CLVT
$2.88B
| $8.17M | ﹤0.01% |
870,426
-58,607
| -6% | -$550K |
|
1587
Liberty Global Class A
LBTYA
$4.05B
| $8.17M | ﹤0.01% |
418,980
-9,072
| -2% | -$177K |
|
1588
Cactus
WHD
$2.74B
| $8.17M | ﹤0.01% |
198,120
-1,574
| -0.8% | -$64.9K |
|
1589
ADT
ADT
$7.24B
| $8.17M | ﹤0.01% |
1,129,598
-8,932
| -0.8% | -$64.6K |
|
1590
Atlantic Union Bankshares
AUB
$5.05B
| $8.16M | ﹤0.01% |
232,688
-43,410
| -16% | -$1.52M |
|
|
PRVB
1591
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $8.13M | ﹤0.01% |
337,165
-74,141
| -18% | -$1.79M |
|
1592
Immunovant
IMVT
$2.82B
| $8.1M | ﹤0.01% |
522,396
+198,478
| +61% | +$3.08M |
|
|
BPMC
1593
DELISTED
Blueprint Medicines
BPMC
| $8.1M | ﹤0.01% |
179,950
-14,647
| -8% | -$659K |
|
1594
Kura Oncology
KURA
$711M
| $8.07M | ﹤0.01% |
660,101
-35,560
| -5% | -$435K |
|
1595
Trustmark
TRMK
$2.43B
| $8.07M | ﹤0.01% |
326,623
+42,338
| +15% | +$1.05M |
|
1596
Arcus Biosciences
RCUS
$1.23B
| $8.05M | ﹤0.01% |
441,241
+298,925
| +210% | +$5.45M |
|
1597
Certara
CERT
$1.81B
| $8.02M | ﹤0.01% |
332,537
+25,900
| +8% | +$624K |
|
1598
Digi International
DGII
$1.33B
| $8M | ﹤0.01% |
237,481
+13,357
| +6% | +$450K |
|
1599
BOK Financial
BOKF
$7.06B
| $7.98M | ﹤0.01% |
94,499
+3,882
| +4% | +$328K |
|
1600
BancFirst
BANF
$4.45B
| $7.93M | ﹤0.01% |
95,393
+7,069
| +8% | +$587K |
|